Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hauske, Sibylle Jenny"'
Autor:
Zannad, Faiez, Ferreira, João Pedro, Gregson, John, Kraus, Bettina Johanna, Mattheus, Michaela, Hauske, Sibylle Jenny, Butler, Javed, Filippatos, Gerasimos, Wanner, Christoph, Anker, Stefan D, Pocock, Stuart J, Packer, Milton, EMPEROR-Reduced Trial Committees and Investigators
AIMS: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) may induce an early post-initiation decrease of estimated glomerular filtration rate (eGFR), which does not impact the SGLT2i benefits. The occurrence, characteristics, determinants, and clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::52af91fd492fbe420549006fbaea6cc9
https://researchonline.lshtm.ac.uk/id/eprint/4666159/1/Zannad_etal_2022_Early-changes-in-estimated-glomerular.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4666159/1/Zannad_etal_2022_Early-changes-in-estimated-glomerular.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zannad, Faiez, Ferreira, João Pedro, Pocock, Stuart J, Zeller, Cordula, Anker, Stefan D, Butler, Javed, Filippatos, Gerasimos, Hauske, Sibylle Jenny, Brueckmann, Martina, Pfarr, Egon, Schnee, Janet, Wanner, Christoph, Packer, Milton
BACKGROUND: In EMPEROR-Reduced (Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Reduced Ejection Fraction), empagliflozin reduced cardiovascular death or heart failure (HF) hospitalization and total HF hospitalizations, and sl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::fafcb617f1147bc0f1fdeedd31fad84b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zannad F; Université de Lorraine, Inserm, Center d'Investigations Cliniques, - Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France., Ferreira JP; Université de Lorraine, Inserm, Center d'Investigations Cliniques, - Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal., Gregson J; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Kraus BJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany.; Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.; Würzburg University Clinic, Würzburg, Germany., Mattheus M; Biostatistics, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany., Hauske SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany.; Vth Department of Medicine, University Medical Center Mannheim, University of Heidelberg, Heidelberg, Germany., Butler J; Baylor Scott and White Research Institute, TX and University of Mississippi, Jackson, MS, USA., Filippatos G; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Wanner C; Würzburg University Clinic, Würzburg, Germany., Anker SD; Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Center for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany., Pocock SJ; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA.; Imperial College, London, UK.
Publikováno v:
European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1829-1839. Date of Electronic Publication: 2022 Jul 07.
Autor:
Zannad F; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM 1116, CHRU de Nancy, FCRIN INI-CRCT, Nancy, France (F.Z., J.P.F.)., Ferreira JP; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM 1116, CHRU de Nancy, FCRIN INI-CRCT, Nancy, France (F.Z., J.P.F.)., Pocock SJ; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK (S.J.P.)., Zeller C; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany (C.Z.)., Anker SD; Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany (S.D.A.)., Butler J; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS. (J.B.)., Filippatos G; National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Athens, Greece (G.F.)., Hauske SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany (S.J.H., M.B.).; Vth Department of Medicine, University Medical Center Mannheim (S.J.H.), University of Heidelberg, Mannheim, Germany., Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany (S.J.H., M.B.).; Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, Germany., Pfarr E; Ingelheim, Germany (E.P.)., Schnee J; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (J.S.).; Division of Nephrology, University Hospital, Würzburg, Germany (J.S.)., Wanner C, Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas TX (M.P.).; Imperial College, London, UK (M.P.).
Publikováno v:
Circulation [Circulation] 2021 Jan 26; Vol. 143 (4), pp. 310-321. Date of Electronic Publication: 2020 Oct 23.